(Q39308063)

10 September 2017

title

Potential roles of interleukin-17A in the development of skin fibrosis in mice (English)

1 reference

10 September 2017

Doanh Le Huu

5

0 references

Takashi Matsushita

object named as

Takashi Matsushita

3

0 references

Yoichiro Iwakura

object named as

Yoichiro Iwakura

6

0 references

author name string

Yoshinobu Okamoto

1

1 reference

10 September 2017

Minoru Hasegawa

2

1 reference

10 September 2017

Yasuhito Hamaguchi

4

1 reference

10 September 2017

Manabu Fujimoto

7

1 reference

10 September 2017

Kazuhiko Takehara

8

1 reference

10 September 2017

publication date

1 November 2012

1 reference

10 September 2017

published in

Arthritis & Rheumatology

1 reference

10 September 2017

volume

64

1 reference

10 September 2017

issue

11

1 reference

10 September 2017

page(s)

3726-3735

1 reference

Systemic sclerosis: a prototypic multisystem fibrotic disorder

10 September 2017

cites work

1 reference

21 January 2018

1 reference

Fibrotic disease and the T(H)1/T(H)2 paradigm

21 January 2018

1 reference

T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

21 January 2018

1 reference

Scleroderma: from cell and molecular mechanisms to disease models

21 January 2018

1 reference

Is systemic sclerosis an antigen-driven T cell disease?

21 January 2018

1 reference

The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes

21 January 2018

1 reference

21 January 2018

1 reference

Functional specialization of interleukin-17 family members

21 January 2018

1 reference

Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent

21 January 2018

1 reference

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

21 January 2018

1 reference

Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin

21 January 2018

1 reference

Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma

21 January 2018

1 reference

Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.

21 January 2018

1 reference

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

21 January 2018

1 reference

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

21 January 2018

1 reference

A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

21 January 2018

1 reference

Impairment of skin wound healing in beta-1,4-galactosyltransferase-deficient mice with reduced leukocyte recruitment

21 January 2018

1 reference

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

21 January 2018

1 reference

IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis

21 January 2018

1 reference

Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.

21 January 2018

1 reference

Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease

21 January 2018

1 reference

Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma

21 January 2018

1 reference

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

21 January 2018

1 reference

Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation

21 January 2018

1 reference

Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells

21 January 2018

1 reference

Late developmental plasticity in the T helper 17 lineage

21 January 2018

1 reference

Criteria to select molecular targets for anti-fibrotic therapy

21 January 2018

1 reference

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

21 January 2018

1 reference

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.34643

1 reference

10 September 2017

1 reference